Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We donβt do fads. We help you feel strong, capable, and in control of your health β with expert guidance every step of the way.
This cohort study of more than 1.6 million patients with type 2 diabetes (T2D) who had no prior diagnosis of 13 OACs found that patients with T2D treated with GLP-1RAs vs insulin had a significant risk reduction in 10 of 13 OACs, including esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer as well as meningioma and multiple myeloma. No decrease in cancer risk was associated with GLP-1RAs compared with metformin.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820833
The benefits of GLP-1 drugs beyond obesity
https://www.science.org/doi/full/10.1126/science.adn4128
Exciting advancements are happening in the world of GLP-1 medications! After nearly 20 years of use for Type 2 Diabetes the future looks even brighter. The next generation of GLP-1 therapies promises to be even more powerful, with potential benefits extending beyond cardiometabolic disorders. Stay tuned as we continue to explore these groundbreaking options for improved health and wellness!
Learn about these exciting advancements during your consultation with our Board-Certified Nurse Practitioners
Telehealth or in-person consultation to evaluate your medical information, discuss your options, and guide you to making the right choice in managing your weight.
Monthly Follow Up, medication management, one-on-one coaching and direct access to Providers.
Cost for completion of prior authorization forms if required when using prescription insurance for brand name Wegovy or Zepbound
Get started today!
GLP-1 (Glucagon-like peptide-1) agonists are innovative medications designed to support weight loss and improve metabolic health. At Fleming Adult Health NP, we follow evidence-based guidelines to ensure these treatments are safe, effective, and tailored to your individual needs.
Hereβs how we approach GLP-1 agonist therapy:
π« BMI Criteria: GLP-1 agonists may be recommended for individuals with a BMI of 30 or higher or a BMI of 27 or higher when weight-related conditions such as high blood pressure, high cholesterol, or type 2 diabetes are present.
π« Weight-Related Comorbidities: These medications are especially beneficial for those managing obesity alongside related health challenges, particularly when other weight-loss methods have not been effective.
π« Individualized Treatment Plans: We carefully assess your health history, current conditions, and past weight-loss experiences to create a personalized treatment plan that fits your goals and lifestyle.
Our goal is to empower you with tools and guidance to achieve and maintain your health and wellness objectives.
Copyright Β© 2025-Fleming Adult Health NP, PLLC- All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.